Study explores links between antidiabetic meds, multiple sclerosis risk

For patients with type 2 diabetes (T2D), exposure to antihyperglycemic medications (A-HgMs) is associated with a decreased risk for developing multiple sclerosis (MS) in those who are younger than 45 years and an increased risk for developing MS in those who are older than 45 years, according to a study published online Oct. 21 in Heliyon.